Vitrification

Vitrification Market Outlook

The global vitrification market was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 2.3 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period of 2025 to 2035. The growth of this market can be attributed to the rising demand for assisted reproductive technologies (ART), the increasing prevalence of infertility issues, and a growing focus on the preservation of biological materials for research and therapeutic purposes. In addition, advancements in cryopreservation technologies and an increase in the number of fertility clinics globally are also significant factors fueling market growth. Furthermore, growing awareness and acceptance of cryopreservation techniques among healthcare professionals and patients alike are expected to further propel the market in the coming years.

Growth Factor of the Market

One of the primary growth factors driving the vitrification market is the increasing prevalence of infertility, which has been a significant concern worldwide. According to the World Health Organization (WHO), approximately 15% of couples experience infertility, leading to a greater need for effective solutions such as in vitro fertilization (IVF) and other ART methods. Additionally, the improved success rates associated with vitrification compared to traditional freezing methods are also contributing to the adoption of this technology. The ability to preserve embryos, oocytes, and other biological materials without ice crystal formation enhances the viability and quality of the preserved specimens, which is crucial for successful pregnancies. An increase in funding for research and development in the field of regenerative medicine is another vital factor that is expected to boost the vitrification market. Furthermore, technological innovations such as automated vitrification systems and the introduction of novel cryoprotectants will likely enhance the efficacy of vitrification, attracting more investments into this segment.

Key Highlights of the Market

• The market is experiencing significant growth due to the rising incidence of infertility globally.
• Technological advancements in cryopreservation methods are improving success rates.
• Increased investment in research and development is propelling market innovation.
• Growing awareness among patients regarding ART options is driving demand.
• The market is witnessing a rise in the establishment of fertility clinics worldwide.

By Product Type

Cryovials:

Cryovials are one of the most significant products in the vitrification market, used primarily for the storage of biological samples such as cells and tissues. These vials are designed to withstand extreme temperatures and prevent contamination, ensuring the integrity of the samples. The demand for cryovials is driven by their widespread use in both clinical and research settings, as they facilitate the long-term preservation of valuable biological materials. Moreover, advancements in cryovial technology, including the development of easy-to-use and cost-effective options, are also contributing to the growth of this segment. As research in fields like regenerative medicine and stem cell therapy continues to expand, the utilization of cryovials is expected to rise, enhancing market prospects.

Cryopreservation Bags:

Cryopreservation bags are another crucial component of the vitrification market, particularly used for the storage of larger volumes of biological materials. These bags are designed for ease of use and optimal preservation of the samples, often featuring multiple compartments to facilitate the storage of various cell types. The burgeoning demand for these bags can be attributed to their increasing application in biobanking and large-scale cell culture activities. Additionally, the growth of the biopharmaceutical industry, which often requires bulk storage solutions, is further amplifying the need for cryopreservation bags. Innovations in materials and designs, which enhance the bags' stability and safety, are also expected to contribute positively to the segment's expansion.

Cryostraws:

Cryostraws serve as a vital tool for the small-scale preservation of biological materials, particularly gametes. These straws are designed to minimize exposure to air and are specifically engineered for optimal cryopreservation. The rising number of fertility treatments and ART procedures is a significant factor boosting the demand for cryostraws. Moreover, their compact size and user-friendly design make them a preferred choice for fertility clinics and laboratories. As the fertility treatment landscape continues to evolve, with more patients seeking assisted reproduction options, the adoption of cryostraws is expected to witness significant growth, thereby reinforcing their critical role in the vitrification market.

Cryotubes:

Cryotubes are widely used in the preservation of oocytes and embryos, allowing for effective long-term storage under cryogenic conditions. These tubes are designed to prevent the formation of ice crystals, which can damage delicate biological specimens. The increasing number of IVF procedures and the rising acceptance of oocyte freezing for later use are driving the demand for cryotubes in the market. They also facilitate streamlined processes in laboratories and clinics, which enhances their attractiveness to healthcare providers. As the field of reproductive medicine continues to expand, the utilization of cryotubes is poised for growth, contributing positively to the overall vitrification market.

Cryowells:

Cryowells are specialized devices used in the vitrification process, providing optimal conditions for the preservation of biological samples. These wells often come with advanced features that facilitate uniform cooling and help prevent the formation of ice crystals. The increasing emphasis on improving the success rates of cryopreservation techniques is a major factor driving the demand for cryowells. Furthermore, their application in research settings, particularly in studies focused on stem cells and tissue preservation, is expected to contribute to their market growth. The ongoing innovations in cryowell technology will likely enhance their functionality, making them a vital component of the vitrification market.

By Application

Embryo Preservation:

Embryo preservation is one of the most critical applications of vitrification, particularly in assisted reproductive technologies such as IVF. This method allows for the long-term storage of embryos, ensuring their viability for future implantation. The increasing number of couples opting for IVF due to infertility issues is driving the demand for embryo preservation solutions. Moreover, advancements in vitrification techniques are improving embryo survival rates post-thaw, further boosting their adoption. As more individuals become aware of the benefits of preserving embryos for later use, the market for this application is expected to see substantial growth in the coming years.

Oocyte Preservation:

The preservation of oocytes, or eggs, has gained significant importance in recent years, especially among women seeking to delay childbirth for personal or professional reasons. Vitrification offers a reliable solution for oocyte storage, ensuring their quality and viability for future use. The rising trend of women choosing to freeze their eggs has been a driving factor in this segment's growth. Additionally, the improvement in freezing technologies and the increasing success rates associated with oocyte preservation are further enhancing its appeal. As awareness of oocyte preservation continues to increase, this segment of the market is expected to expand significantly.

Sperm Preservation:

Sperm preservation is essential for men undergoing medical treatments that may affect their fertility, such as chemotherapy or surgery. Vitrification methods are utilized to ensure the long-term storage of sperm, maintaining its viability for future use. The rising awareness regarding fertility preservation options among men is a significant factor contributing to this segment's growth. Furthermore, the increasing number of sperm banks and the growing acceptance of sperm donation are also boosting demand. As advancements in cryopreservation technologies continue to arise, the effectiveness and reliability of sperm preservation are expected to improve, driving further market expansion.

Stem Cell Preservation:

Stem cell preservation is a vital application of vitrification, particularly in the fields of regenerative medicine and transplantation. The ability to store stem cells effectively allows for their future use in various therapies, enhancing patient outcomes. The growing prevalence of diseases that require stem cell therapy, such as certain cancers and genetic disorders, is significantly driving demand in this area. Additionally, the increasing focus on research and clinical trials involving stem cells is amplifying the need for reliable preservation methods. As advancements in stem cell technology continue, the vitrification market for this application is poised for robust growth.

Tissue Preservation:

Tissue preservation using vitrification techniques is becoming more prevalent, especially in the fields of transplant medicine and regenerative therapies. The ability to preserve tissues without ice crystal formation ensures their viability for future transplantation or research purposes. The increasing need for organ and tissue donations and the growth of biobanks are vital factors contributing to the demand for tissue preservation. Furthermore, the ongoing research into advanced tissue engineering and regenerative medicine is expected to augment the market for this application. As the medical community continues to explore innovative solutions for tissue preservation, the vitrification market in this segment is anticipated to expand significantly.

By Distribution Channel

Hospitals & Clinics:

Hospitals and clinics are major distribution channels for vitrification products, primarily due to the increasing number of assisted reproductive technology (ART) procedures being performed globally. These institutions typically have the infrastructure and trained personnel to utilize vitrification methods effectively, which further drives demand. The growing patient population seeking fertility treatments has led to a rise in partnerships between hospitals and vitrification product manufacturers, ensuring an adequate supply of necessary materials. Furthermore, hospitals and clinics continuously invest in advanced technologies, including automated vitrification systems, which is expected to positively impact the growth of this channel.

Biotechnology & Pharmaceutical Companies:

Biotechnology and pharmaceutical companies are significant players in the vitrification market, as they often require high-quality preservation solutions for their research and development activities. These organizations utilize vitrification for various applications, including the preservation of cell cultures, drug development, and clinical trials. The increasing focus on biopharmaceutical research and the growing need for effective preservation methods to maintain sample integrity are driving demand from this channel. Moreover, advancements in biotechnology are leading to innovative applications of vitrification, further enhancing its importance within the sector.

Cryobanks:

Cryobanks play a crucial role in the distribution of vitrification products, especially for the preservation of human gametes, embryos, and stem cells. These specialized storage facilities are dedicated to the long-term preservation of biological materials, ensuring their viability for future use. The increasing number of cryobanks and the growing awareness of their services are significant factors contributing to the demand for vitrification solutions. Additionally, as the number of fertility treatments rises, the need for reliable and safe storage options becomes even more critical. The expansion of cryobanks will likely drive growth in this segment, further solidifying their importance in the vitrification market.

Research Institutes:

Research institutes are essential players in the vitrification market, as they often conduct studies that require the preservation of biological samples. These organizations utilize vitrification techniques for a variety of applications, including stem cell research and regenerative medicine. The increasing funding for scientific research and the growing emphasis on innovative medical solutions are boosting demand for vitrification products within this channel. Furthermore, research institutes are continuously exploring new methods and technologies for sample preservation, which is expected to influence advancements in the vitrification market positively.

Others:

Other distribution channels for vitrification products include academic institutions, private laboratories, and fertility centers, among others. These entities utilize vitrification methods for various applications, including research and reproductive medicine. The increasing awareness of the benefits of cryopreservation techniques among different stakeholders is driving demand across these channels. Furthermore, as more institutions and laboratories focus on developing new treatments and therapies, the need for effective preservation solutions will likely grow. This segment's growth is anticipated as the market diversifies and more end-users recognize the advantages of vitrification.

By Ingredient Type

EG:

Ethylene glycol (EG) is a widely used cryoprotectant in vitrification processes due to its effectiveness in preventing ice crystal formation. Its low toxicity and ability to permeate cell membranes make it an ideal choice for preserving various biological materials. The growing demand for EG in the vitrification market can be attributed to its application in assisted reproductive technologies and regenerative medicine. Additionally, as researchers continue to explore new cryopreservation methods, the use of EG is expected to expand, thereby positively impacting market growth.

DMSO:

Dimethyl sulfoxide (DMSO) is another essential cryoprotectant utilized in the vitrification market. It is known for its ability to protect cells from freezing damage while maintaining their viability. The increasing acceptance of DMSO in various preservation techniques, particularly in the field of stem cell research, is driving its demand. As the focus on regenerative medicine and cell therapies continues to grow, the use of DMSO in vitrification processes is expected to rise, enhancing market prospects. Furthermore, ongoing research into optimizing DMSO formulations for better results will likely contribute to this segment's growth.

Sucrose:

Sucrose serves as an important osmotic agent in vitrification solutions, helping to stabilize cells during the freezing and thawing process. Its ability to protect biological samples from osmotic shock is crucial for maintaining cell integrity. The demand for sucrose in the vitrification market is driven by its application in various cryopreservation techniques, particularly in assisted reproductive technologies. As more patients seek fertility treatments and the need for effective preservation methods increases, the utilization of sucrose in vitrification solutions is expected to grow consistently in the coming years.

PVP:

Polyvinylpyrrolidone (PVP) is a synthetic polymer that is used as a cryoprotectant in various vitrification applications. Its ability to form stable complexes with other substances enhances the viability of preserved biological materials. The growing interest in PVP as a viable option for cryopreservation is primarily driven by advancements in research and technology. As more studies highlight its benefits in maintaining cell integrity during storage, the demand for PVP in the vitrification market will likely increase, providing opportunities for market expansion.

Ficoll:

Ficoll is a polysaccharide that is commonly used as a cryoprotectant and density gradient medium in vitrification processes. Its properties enable the effective separation and preservation of various cell types, making it particularly valuable in stem cell research and other applications. The increasing focus on regenerative medicine and the need for reliable preservation solutions are driving the demand for Ficoll in the vitrification market. As research progresses and new applications for Ficoll emerge, its use in cryopreservation is expected to expand, further enhancing its significance within the industry.

By Region

The vitrification market is experiencing significant growth across various regions, each contributing uniquely to the overall market dynamics. North America holds a substantial share of the market, with a valuation of approximately USD 500 million in 2023. This region benefits from advanced healthcare infrastructure, increased awareness of assisted reproductive technologies, and a high prevalence of infertility issues. Additionally, the increasing number of fertility clinics and ongoing research activities in the field of regenerative medicine further bolster the region's market prospects. The CAGR for the North American vitrification market is projected to be around 7% during the forecast period, highlighting its strong growth potential in the coming years.

In Europe, the vitrification market is also witnessing notable growth, driven by favorable government policies and funding for fertility treatments and advancements in cryopreservation technologies. The European market was valued at around USD 400 million in 2023, with a significant focus on research and development in the healthcare sector. The increasing number of fertility centers and clinics, along with rising consumer awareness about reproductive health, are further contributing to the growth of the market. Meanwhile, the Asia Pacific region is rapidly emerging as a key player in the vitrification market, with a growing valuation of approximately USD 300 million as of 2023. The rise in disposable incomes, changing lifestyles, and increased awareness of ART options among the population are significant factors driving the market's expansion in this region.

Opportunities

The vitrification market presents numerous opportunities for growth, particularly in the development and expansion of fertility clinics and cryobanks. As more individuals seek fertility treatments and explore options for preserving their biological materials for future use, the demand for vitrification products is expected to rise significantly. This trend is supported by the increasing awareness and acceptance of assisted reproductive technologies among the general public. Additionally, the growing prevalence of fertility-related issues globally, along with advancements in cryopreservation technologies, will likely create opportunities for businesses to innovate and introduce new products to meet the evolving needs of healthcare providers and patients alike. Furthermore, the integration of automated systems in vitrification processes can enhance efficiency and scalability, allowing organizations to serve a broader clientele.

Another key opportunity lies in the realm of research and development in regenerative medicine and stem cell therapies. As scientific exploration in these areas deepens, the need for effective preservation methods will become increasingly critical. This creates an avenue for companies to invest in cutting-edge technologies that can enhance the efficacy of vitrification techniques. Additionally, collaborations between academic institutions, research organizations, and private companies can lead to the development of novel solutions that address specific challenges faced in cryopreservation. By capitalizing on these opportunities, stakeholders in the vitrification market can position themselves favorably for long-term growth and success.

Threats

Despite the potential for growth, the vitrification market is not without its challenges. One of the primary threats is the presence of stringent regulations governing the use of cryopreservation technologies in different regions. These regulations can vary significantly, making it difficult for companies to navigate compliance requirements and potentially hindering their ability to bring products to market efficiently. Moreover, the need for extensive validation and testing of vitrification products can create barriers for new entrants, limiting competition and hindering innovation within the industry. Additionally, fluctuations in the availability and cost of raw materials used in vitrification solutions can impact production processes and overall market dynamics.

Another significant threat facing the vitrification market is the competition from alternative preservation methods. Techniques such as slow freezing and other cryopreservation systems continue to be utilized, particularly in certain segments of the market. If these alternative methods demonstrate improved efficacy or lower costs, they may pose a challenge to the widespread adoption of vitrification technologies. Furthermore, the ongoing research into novel preservation techniques may lead to the emergence of new competitors that could disrupt the current market landscape. As such, companies operating in the vitrification market must remain vigilant and adaptive to the evolving competitive environment to sustain their market position.

Competitor Outlook

• Vitrolife
• Fertility Solutions
• Cook Medical
• Thermo Fisher Scientific
• Reprotech, LLC
• IVF Technologies
• Cryo Bio System
• Corning Incorporated
• Hamilton Thorne
• BioLife Sciences
• Stemcell Technologies
• Vitro Dynamics
• Asymmetrex
• Cell Preservation Services
• In Vitro Services

The competitive landscape of the vitrification market is characterized by a mix of established players and emerging companies. Major players such as Vitrolife and Cook Medical have established a strong presence in the market, leveraging their extensive experience and expertise in reproductive technologies and cryopreservation solutions. These companies continuously invest in research and development to enhance their product offerings, catering to the evolving needs of healthcare providers and patients. Additionally, strategic partnerships and collaborations with academic institutions and fertility clinics have enabled these players to expand their market reach and drive innovation in vitrification techniques.

Companies like Thermo Fisher Scientific and Reprotech, LLC are also prominent contenders in the market, focusing on developing advanced vitrification products and solutions. Their commitment to quality and innovation has allowed them to maintain a competitive edge, positioning themselves favorably within the industry. Moreover, as the demand for fertility treatments and biological preservation options continues to rise, these companies are well-prepared to capitalize on emerging trends and opportunities in the vitrification market.

Furthermore, the presence of numerous small and mid-sized companies, including IVF Technologies and Cryo Bio System, indicates a dynamic and competitive environment. These organizations often focus on niche markets or specialized applications within the vitrification segment, providing tailored solutions to meet specific client needs. As research and technology continue to advance, the competitive landscape is expected to evolve, with companies striving to differentiate themselves through innovation, product quality, and customer service. Overall, the vitrification market is poised for continued growth, driven by a combination of established players and new entrants seeking to address the growing demand for preservation solutions in reproductive medicine and research.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Vitrolife
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Asymmetrex
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Cook Medical
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Reprotech, LLC
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Vitro Dynamics
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Cryo Bio System
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hamilton Thorne
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 BioLife Sciences
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 IVF Technologies
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 In Vitro Services
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Fertility Solutions
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Corning Incorporated
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Stemcell Technologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Cell Preservation Services
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Vitrification Market, By Application
    • 6.1.1 Embryo Preservation
    • 6.1.2 Oocyte Preservation
    • 6.1.3 Sperm Preservation
    • 6.1.4 Stem Cell Preservation
    • 6.1.5 Tissue Preservation
  • 6.2 Vitrification Market, By Product Type
    • 6.2.1 Cryovials
    • 6.2.2 Cryopreservation Bags
    • 6.2.3 Cryostraws
    • 6.2.4 Cryotubes
    • 6.2.5 Cryowells
  • 6.3 Vitrification Market, By Ingredient Type
    • 6.3.1 EG
    • 6.3.2 DMSO
    • 6.3.3 Sucrose
    • 6.3.4 PVP
    • 6.3.5 Ficoll
  • 6.4 Vitrification Market, By Distribution Channel
    • 6.4.1 Hospitals & Clinics
    • 6.4.2 Biotechnology & Pharmaceutical Companies
    • 6.4.3 Cryobanks
    • 6.4.4 Research Institutes
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Vitrification Market by Region
  • 10.4 Latin America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 Brazil
      • 10.4.1.2 Argentina
      • 10.4.1.3 Mexico
  • 10.5 North America - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 USA
      • 10.5.1.2 Canada
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Vitrification market is categorized based on

By Product Type

• Cryovials
• Cryopreservation Bags
• Cryostraws
• Cryotubes
• Cryowells

By Application

• Embryo Preservation
• Oocyte Preservation
• Sperm Preservation
• Stem Cell Preservation
• Tissue Preservation

By Distribution Channel

• Hospitals & Clinics
• Biotechnology & Pharmaceutical Companies
• Cryobanks
• Research Institutes
• Others

By Ingredient Type

• EG
• DMSO
• Sucrose
• PVP
• Ficoll

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Vitrolife
• Fertility Solutions
• Cook Medical
• Thermo Fisher Scientific
• Reprotech, LLC
• IVF Technologies
• Cryo Bio System
• Corning Incorporated
• Hamilton Thorne
• BioLife Sciences
• Stemcell Technologies
• Vitro Dynamics
• Asymmetrex
• Cell Preservation Services
• In Vitro Services